The RTTN gene encodes centriole biogenesis, replication, symmetry and cohesion, basal body organization and has recently been associated with the appearance of microcephaly syndromes. RTTN-related neurological defects including microcephaly, intellectual disability, congenital dwarfism, ophthalmic manifestations, and epilepsy are mainly due to abnormal brain development pathways and loss-of-function protein mutations. We present a consanguineous Pakistani family clinically suspected of Seckel syndrome with severe microcephaly, severe intellectual disability, short stature, absence of speech, pointed nose, narrow face and bilateral cataract in two siblings residing in the suburbs of Islamabad. Forty cases of Seckel syndrome have been reported to date in the literature due to mutations in the ATR, TRAIP, RBBP8, NSMCE2, NIN, CENPJ, DNA2, CEP152 and CEP63 genes. The objective of the study was to perform a clinical diagnosis, genetic analysis, and pathophysiology of Seckel syndrome in the proband. Whole-exome sequencing discovered NM_173630.4: c.57G > T(pGlu19Asp) missense variant in exon 2 of the RTTN gene that co-segregates in the family. This novel variant, to the best of our knowledge, is pathogenic and with autosomal recessive inheritance expressed as Seckel syndrome in the affected members of the family. The present study has expanded the genetic knowledge of novel RTTN gene variants associated with Seckel syndrome and has broadened its phenotype spectrum in the Pakistani population, which comprises diverse ethnicities. We hope that our study will open new horizons for individual molecular diagnosis and therapeutics to improve the life of patients with this congenital syndrome.
• Background: The genetics of neurodevelopmental disorders is partially investigated due to the multiple additive risk factors found to be involved. Emergence of individual genes implicated across multiple diseases suggests that they might share similar underlying driving pathways. The CNTNAP2 gene is an excellent presentation, that has been found in a variety of phenotypes. The role of CNTNAP2 is implicated in a vast number of neural and genetic networks of neurodevelopment which leads to the understanding of regulation and function of this gene. The diverse roles of CNTNAP2 can enhance our understanding of how combinations of individual genetic risk factors can contribute to the complexity of neurodevelopmental disorders. • Methods: The present study aims to investigate the role of CNTNAP2 polymorphism as a risk factor for comorbidity of Intellectual Disability and epilepsy in Pakistani population. 170 patients and 175 healthy controls took part in this study from different areas of Pakistan. Genotyping using Tetra-primer ARMS PCR technique was conducted to investigate the association between rs147815978 (G/T) and rs2710102 (A/G) of CNTNAP2 gene and intellectual disability and epilepsy co-occurrence in patients of different age groups. • Results: The genotyping data was analysed to trace the effect of CNTNAP2 polymorphism on the comorbidity of ID and EPI diseases in study participants. Probability values less than 0.05 were considered significant for the association of CNTNAP2 rs147815978 and rs2710102. Results suggested a probable role of CNTNAP2 gene polymorphism predisposition to comorbidity of neurodevelopmental disorders in Pakistani population. • Conclusion: CNTNAP2 polymorphisms have a significant role in co-occurrence of NDDs due to the underlying shared molecular mechanisms causing neurodevelopment. • Trial Registration: Not Applicable for this study. Ethical approval from Ethical Review Committee of Department of Biosciences, Comsats University Islamabad campus was obtained prior to conduction of all procedures.
· Background: The genetics of neurodevelopmental disorders is partially investigated due to the multiple additive risk factors found to be involved. Emergence of individual genes implicated across multiple diseases suggests that they might share similar underlying driving pathways. The CNTNAP2 gene is an excellent presentation, that has been found in a variety of phenotypes. The role of CNTNAP2 is implicated in a vast number of neural and genetic networks of neurodevelopment which leads to the understanding of regulation and function of this gene. The diverse roles of CNTNAP2 can enhance our understanding of how combinations of individual genetic risk factors can contribute to the complexity of neurodevelopmental disorders. · Methods: The present study aims to investigate the role of CNTNAP2 polymorphism as a risk factor for comorbidity of Intellectual Disability and epilepsy in Pakistani population. 170 patients and 175 healthy controls took part in this study from different areas of Pakistan. Genotyping using Tetra-primer ARMS PCR technique was conducted to investigate the association between rs147815978 (G/T) and rs2710102 (A/G) of CNTNAP2 gene and intellectual disability and epilepsy co-occurrence in patients of different age groups. · Results: The genotyping data was analysed to trace the effect of CNTNAP2polymorphism on the comorbidity of ID and EPI diseases in study participants. Probability values less than 0.05 were considered significant for the association of CNTNAP2 rs147815978 and rs2710102. Results suggested a probable role of CNTNAP2 gene polymorphism predisposition to comorbidity of neurodevelopmental disorders in Pakistani population. · Conclusion: CNTNAP2 polymorphisms have a significant role in co-occurrence of NDDs due to the underlying shared molecular mechanisms causing neurodevelopment. · Trial Registration: Not Applicable for this study. Ethical approval from Ethical Review Committee of Department of Biosciences, Comsats University Islamabad campus was obtained prior to conduction of all procedures.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.